Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coolen

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1P<sub>5</sub> receptor agonist chemotypeAxel R Stoit, Jos H M Lange, Hein K A C Coolen, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2005
Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicityJos H M Lange, Herman H van Stuivenberg, Willem Veerman, et al.
Frontiers in Immunology|December 21, 2016
Transitional B Cells in Early Human B Cell Development - Time to Revisit the Paradigm?Victoria G Martin, Yu-Chang Bryan Wu, Catherine L Townsend, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
7-Azaindole derivatives as potential partial nicotinic agonistsAxel R Stoit, Arnold P den Hartog, Harry Mons, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|February 18, 2011
How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biologyGilbert O Fruhwirth, Luis P Fernandes, Gregory Weitsman, et al.
Journal of Medicinal Chemistry|March 18, 2005
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonistsJos H M Lange, Herman H van Stuivenberg, Hein K A C Coolen, et al.
Oncotarget|September 14, 2016
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC statusGregory Weitsman, Paul R Barber, Lan K Nguyen, et al.
Journal of the National Cancer Institute|December 19, 2019
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal TrialPaul R Barber, Gregory Weitsman, Katherine Lawler, et al.
Ebiomedicine|February 20, 2026
Fusing data from CT deep learning, CT radiomics and peripheral blood immune profiles to diagnose lung cancer in a cohort of patients experiencing symptomsRami Mustapha, Balaji Ganeshan, Sam Ellis, et al.
Journal of Medicinal Chemistry|October 28, 2005
Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibitionPieter Smid, Hein K A C Coolen, Hiskias G Keizer, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1P<sub>5</sub> receptor agonist chemotypeAxel R Stoit, Jos H M Lange, Hein K A C Coolen, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2005
Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicityJos H M Lange, Herman H van Stuivenberg, Willem Veerman, et al.
Frontiers in Immunology|December 21, 2016
Transitional B Cells in Early Human B Cell Development - Time to Revisit the Paradigm?Victoria G Martin, Yu-Chang Bryan Wu, Catherine L Townsend, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
7-Azaindole derivatives as potential partial nicotinic agonistsAxel R Stoit, Arnold P den Hartog, Harry Mons, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|February 18, 2011
How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biologyGilbert O Fruhwirth, Luis P Fernandes, Gregory Weitsman, et al.
Journal of Medicinal Chemistry|March 18, 2005
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonistsJos H M Lange, Herman H van Stuivenberg, Hein K A C Coolen, et al.
Oncotarget|September 14, 2016
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC statusGregory Weitsman, Paul R Barber, Lan K Nguyen, et al.
Journal of the National Cancer Institute|December 19, 2019
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal TrialPaul R Barber, Gregory Weitsman, Katherine Lawler, et al.
Ebiomedicine|February 20, 2026
Fusing data from CT deep learning, CT radiomics and peripheral blood immune profiles to diagnose lung cancer in a cohort of patients experiencing symptomsRami Mustapha, Balaji Ganeshan, Sam Ellis, et al.
Journal of Medicinal Chemistry|October 28, 2005
Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibitionPieter Smid, Hein K A C Coolen, Hiskias G Keizer, et al.
Pageof 6